Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CV9202
CV9202
Boehringer pairs its lung cancer drug with a vaccine in $600M tie-up with CureVac
Fierce Biotech
Thu, 09/18/14 - 09:57 am
Boehringer Ingelheim
vaccines
CureVac
lung cancer
CV9202